Evaluation of Questionnaires of Tumor Patients With and Without Additive Homeopathic Therapy

This study is currently recruiting participants.

Verified by Medical University of Vienna, March 2009

First Received: March 12, 2009 No Changes Posted

Sponsored by:	Medical University of Vienna
Information provided by:	Medical University of Vienna
ClinicalTrials.gov Identifier:	NCT00861432

Purpose

Tumor patients receiving conventional tumor therapies may choose to receive additional homeopathic therapy. The patients are randomized into two groups receiving either additive homeopathic therapy or not. Two questionnaires referring to subjective feeling and life quality are filled out by the patients with each visit to the outpatients Department. One of them is the QLQC30 questionnaire of the EORTC. The results of the questionnaires of the two groups are compared.

Condition	Intervention	Phase
Tumor	Other: additive homeopathic treatment Other: No additive homeopathic treatment	Phase IV

MedlinePlus related topics: Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study

Further study details as provided by Medical University of Vienna:

Primary Outcome Measures:

Difference with regard to subjective feeling and life quality with or without homeopathic treatment [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment:	400
Study Start Date:	December 2008
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
additive homeopathic treatment: Active Comparator	Other: additive homeopathic treatment These patients receive homeopathic treatment
no additive homeopathic treatment: No Intervention These patients do not receive homeopathic treatment	Other: No additive homeopathic treatment These patients do not receive homeopathic treatment

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: - Tumor patients between 18 and 100 years old

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00861432

Locations

Austria
Med. Univ. Vienna, Dept. Internal Med. I	Recruiting
Vienna, Austria, A1090
Contact: Michael Frass, MD +436645453040 michael.frass@meduniwien.ac.at
Principal Investigator: Michael Frass, MD

Sponsors and Collaborators

Medical University of Vienna

More Information

No publications provided

Responsible Party:	Dept Internal Medicine I ( Medical University Vienna )
Study ID Numbers:	2341
Study First Received:	March 12, 2009
Last Updated:	March 12, 2009
ClinicalTrials.gov Identifier:	NCT00861432 History of Changes
Health Authority:	Austria: Ethikkommission

Keywords provided by Medical University of Vienna:

Life quality
questionnaire
tumor patients

Study placed in the following topic categories:

Quality of Life

ClinicalTrials.gov processed this record on May 07, 2009